search
Back to results

Lung Function of Asthmatic Children by Nebulized MgSO4

Primary Purpose

Asthma

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Magnesium Sulfate & albuterol
albuterol
magnesium
Sponsored by
Chongqing Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthma focused on measuring magnesium sulfate, nebulization, lung function

Eligibility Criteria

4 Years - 10 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • asthmatic children with controlled clinical manifestation

Exclusion Criteria:

  • fever
  • history of chronic disease like bronchopulmonary dysplasia or cystic fibrosis
  • allergic to acetylcholine, albuterol or magnesium
  • use any bronchodilator agents before the Clinic day

Sites / Locations

  • Center of Respiratory Disorders,Children's Hospital,Chongqing medical university

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Experimental

Arm Label

nebulization ms and albuterol

nebulized albuterol

nebulized ms

Arm Description

magnesium sulfate 150mg & albuterol 2.5mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once

albuterol 2.5mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once

magnesium sulfate 150mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once

Outcomes

Primary Outcome Measures

changes of lung function
to observe changes of Forced expiratory volume in one second and peak expiratory flow in controlled asthmatic children after respectively nebulized MgSO4、albuterol and combination of MgSO4 and albuterol in lung function test.

Secondary Outcome Measures

Nebulized magnesium sulfate alone effectively improve lung function
After Ach challenge,FEV1 and PEF decreased in all three groups.But only in albuterol and magnesium group,they presented statistically significant while not in combination therapy group.After each intervention, FEV1 and PEF increased.But there was only statistically significant in FEV1 of magnesium and PEF of albuterol at 10 minutes and these two treatment at 20 minutes
the number of participants with adverse events as a measure of safety and tolerability
to observe if anyone appear side effects such as nausea, vomiting, hypotension et al in patients who participating in our experiment. we did not found adverse reaction or other side effect in the study.

Full Information

First Posted
November 23, 2012
Last Updated
May 17, 2013
Sponsor
Chongqing Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT01799109
Brief Title
Lung Function of Asthmatic Children by Nebulized MgSO4
Official Title
Lung Function Changes of Mild to Moderate Asthmatic Children Treated by Nebulized MgSO4
Study Type
Interventional

2. Study Status

Record Verification Date
May 2013
Overall Recruitment Status
Completed
Study Start Date
November 2011 (undefined)
Primary Completion Date
January 2012 (Actual)
Study Completion Date
March 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chongqing Medical University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Asthma is a common chronic respiratory illness which results in frequent wheezing, cough,reduced quality of life. Standard treatment for asthma attack includes oxygen therapy, β2-agonists (e.g. albuterol) and inhaled anticholinergics and corticosteroids. Although inhaled short-acting β2-agonists (SAB) is the initial choice to control acute asthma exacerbation, there are still some asthmatic children unresponsive to this management. The Global Initiative in National Asthma (GINA) does not recommend intravenous magnesium sulfate (MgSO4) for routine use in asthma exacerbation especially in young children. But intravenous MgSO4 can reduce hospital admission rates in certain patients due to several effects e.g relaxation of smooth muscle,blocking acetylcholine. In addition,adding MgSO4 to nebulized SAB provides greater benefit in severe asthma exacerbation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
magnesium sulfate, nebulization, lung function

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
90 (Actual)

8. Arms, Groups, and Interventions

Arm Title
nebulization ms and albuterol
Arm Type
Experimental
Arm Description
magnesium sulfate 150mg & albuterol 2.5mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once
Arm Title
nebulized albuterol
Arm Type
Active Comparator
Arm Description
albuterol 2.5mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once
Arm Title
nebulized ms
Arm Type
Experimental
Arm Description
magnesium sulfate 150mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once
Intervention Type
Drug
Intervention Name(s)
Magnesium Sulfate & albuterol
Intervention Type
Drug
Intervention Name(s)
albuterol
Intervention Type
Drug
Intervention Name(s)
magnesium
Primary Outcome Measure Information:
Title
changes of lung function
Description
to observe changes of Forced expiratory volume in one second and peak expiratory flow in controlled asthmatic children after respectively nebulized MgSO4、albuterol and combination of MgSO4 and albuterol in lung function test.
Time Frame
10minutes and 20minutes post-dose
Secondary Outcome Measure Information:
Title
Nebulized magnesium sulfate alone effectively improve lung function
Description
After Ach challenge,FEV1 and PEF decreased in all three groups.But only in albuterol and magnesium group,they presented statistically significant while not in combination therapy group.After each intervention, FEV1 and PEF increased.But there was only statistically significant in FEV1 of magnesium and PEF of albuterol at 10 minutes and these two treatment at 20 minutes
Time Frame
10minutes and 20minutes post-dose
Title
the number of participants with adverse events as a measure of safety and tolerability
Description
to observe if anyone appear side effects such as nausea, vomiting, hypotension et al in patients who participating in our experiment. we did not found adverse reaction or other side effect in the study.
Time Frame
20minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: asthmatic children with controlled clinical manifestation Exclusion Criteria: fever history of chronic disease like bronchopulmonary dysplasia or cystic fibrosis allergic to acetylcholine, albuterol or magnesium use any bronchodilator agents before the Clinic day
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jihong Dai, professor
Organizational Affiliation
Chongqing Medical University
Official's Role
Study Director
Facility Information:
Facility Name
Center of Respiratory Disorders,Children's Hospital,Chongqing medical university
City
Chongqing
State/Province
Chongqing
ZIP/Postal Code
400014
Country
China

12. IPD Sharing Statement

Learn more about this trial

Lung Function of Asthmatic Children by Nebulized MgSO4

We'll reach out to this number within 24 hrs